Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study.

CONCLUSIONS Early Tac conversion from Bid-Tac to OD-Tac is safe and feasible. However, further studies are needed to elucidate its long-term effects.
PMID: 30310047 [PubMed - in process]

Source: Annals of Transplantation - October 12, 2018 Category: Transplant Surgery Authors: Lee EC, Kim SH, Park SJ Tags: Ann Transplant Source Type: research